lynda

Birch Pollen Allergy Pipeline Therapeutics Development Review H2 2015

Press Release   •   Aug 26, 2015 08:13 EDT

Birch Pollen Allergy - Pipeline Review, H2 2015

RnRMarketResearch.com Adds “Birch Pollen Allergy - Pipeline Review, H2 2015” which provides an overview of the Birch Pollen Allergy pipeline.

This report provides comprehensive information on the therapeutic development for Birch Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Complete report on H2, 2015 Pipeline Review of “Birch Pollen Allergy” addition with 21 market data tables and 9 figures, spread across 49 pages is http://www.rnrmarketresearch.com/birch-pollen-allergy-pipeline-review-h2-2015-market-report.html .

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from our proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by our professional's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Drugs Profile Discussed in this Research:

Allergen for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis, Allergen for Birch Pollen Induced Allergic Rhinoconjunctivitis, AllerT, Birch-SPIRE, BM-31, PL-102, rBet v1, rBet v1-FV and STG-210

Companies Discussed/Mentioned in this Research:

ALK-Abello A/S, Allergopharma Joachim Ganzer KG, Anergis SA, Biomay AG, Circassia Pharmaceuticals Plc, HAL Allergy BV and Stallergenes S.A.

Inquire before buying for this report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=411446 . (This is a premium report price at US$2000 for a single user PDF license)

Scope:

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Birch Pollen Allergy
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Birch Pollen Allergy pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Reasons to buy:

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Birch Pollen Allergy
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Birch Pollen Allergy pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Explore More Research Report on Allergy Drugs Market.

An allergy is a common problem and most people are allergic to something or the other. The severity of allergy may vary from one person to another. There are a lot of different components to which a person can develop allergy.

It is basically categorized as the disorder which arises when the immune system of the body suddenly reacts in a negative manner to a substance which is otherwise considered harmful. The problem with allergy is that it may get extremely severe and lead to a lot of complications in the future.

Some cases of allergies can be very severe as people have died in less than a few moments of consuming the product they are allergic to. There are a wide variety of allergic drugs that are available in the market. These drugs help in suppressing the reaction of the immune system to the allergic compound and thus are specific depending upon the product you are allergic to.

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries